+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Veterinary Lyme Disease Vaccine Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6149749
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Veterinary Lyme Disease Vaccine Market is projected to reach USD 174.47 Million in 2026. It is expected to continue growing at a CAGR of 6.87%, reaching USD 259.75 Million by 2032.

Veterinary Lyme Disease Vaccines: Executive Summary

Veterinary Lyme disease vaccines are preventive tools intended to reduce infection risk and disease burden in susceptible animals, particularly dogs exposed to Borrelia burgdorferi through infected ticks. Market development is shaped by tick ecology, veterinary awareness, animal ownership, diagnostic practices, vaccination protocols, product safety expectations, and access to routine preventive care. Because Lyme disease risk varies substantially by location and animal lifestyle, adoption depends on region-specific epidemiology and veterinarian-guided assessment rather than a uniform vaccination approach.

Tick Expansion and Preventive-Care Integration Are Reshaping the Landscape

The landscape is changing as tick populations expand or shift geographically, seasonal activity becomes less predictable, and companion animals travel more frequently. These conditions increase the importance of integrated prevention combining vaccination where appropriate with acaricide use, tick checks, environmental management, and owner education. Veterinary practices are also placing greater emphasis on lifecycle preventive care, documented immunization schedules, risk-based consultation, and communication of vaccine benefits and limitations. Regulatory scrutiny, cold-chain requirements, adverse-event monitoring, and the need to distinguish vaccination from treatment remain important considerations.

Artificial Intelligence Improves Risk Assessment, Surveillance, and Veterinary Workflows

Artificial intelligence can strengthen Lyme disease prevention by combining tick surveillance, climate variables, geographic information, animal movement, clinical records, and diagnostic results to identify changing exposure patterns. Decision-support tools may help veterinarians tailor discussions to an animal’s location, outdoor activity, travel history, and prior vaccination status. AI can also support reminder systems, inventory planning, pharmacovigilance, and analysis of diagnostic data. Its value depends on representative datasets, transparent validation, protection of veterinary and owner information, and continued professional oversight; AI should support clinical judgment rather than replace it.

Regional Insights: Prevention Priorities Reflect Distinct Tick and Veterinary Systems

North America remains strongly influenced by established Lyme disease awareness, regional tick exposure, companion-animal preventive care, and veterinary guidance. Europe faces heterogeneous tick distribution, differing national protocols, and varied access to vaccination and diagnostics. Asia-Pacific combines advanced veterinary systems in some markets with emerging awareness and uneven surveillance elsewhere. Latin America’s priorities are shaped by diverse climates, expanding pet ownership, variable diagnostic capacity, and differing evidence on local pathogen and vector patterns. In the Middle East, heat, arid conditions, importation, and localized vector habitats create distinct risk profiles. Africa presents substantial geographic variation, limited surveillance in many areas, and a need to align prevention with local veterinary infrastructure and confirmed disease ecology.

Group Insights: Economic and Institutional Blocs Have Different Adoption Conditions

ASEAN markets are characterized by varied veterinary capacity, tropical and subtropical vector environments, cross-border animal movement, and uneven preventive-care access. BRICS members span highly diverse climates, health systems, regulatory structures, and surveillance capabilities, making locally validated evidence important. The European Union benefits from shared regulatory principles while retaining national differences in veterinary practice and reimbursement. G7 countries generally have mature companion-animal care systems, established research capacity, and strong expectations for safety and evidence. GCC markets require attention to imported animals, pet mobility, specialized veterinary services, and climate-specific vector surveillance. NATO members encompass diverse exposure zones, but military, working, and companion-animal mobility can reinforce the need for coordinated prevention and documentation.

Country Insights: National Ecology, Regulation, and Veterinary Practice Drive Local Priorities

Australia requires careful differentiation between local tick ecology and imported or travel-associated risks. Brazil combines diverse biomes, substantial animal populations, and uneven access to veterinary diagnostics and preventive care. Canada and the United States have regionally concentrated Lyme disease exposure and established awareness of tick prevention. China and India contain wide ecological and income differences, requiring localized surveillance and veterinary education. Japan and South Korea have advanced companion-animal services alongside distinct vector and regulatory conditions. France, Germany, Italy, and Spain reflect varied European exposure patterns, national guidance, and access to preventive services. The United Kingdom places emphasis on regional risk, travel, and integrated tick control. Mexico faces heterogeneous climates, animal mobility, and variable diagnostic capacity. Russia spans multiple ecological zones and requires geographically specific surveillance. Across all countries, vaccination decisions should be aligned with veterinary assessment, product authorization, and the animal’s exposure profile.

Action Priorities for Leaders: Build Evidence-Based, Integrated Prevention Programs

Industry leaders should prioritize regionally relevant evidence that links tick exposure, clinical outcomes, diagnostic interpretation, and vaccination decisions. Product and service strategies should support veterinarians with clear labeling, practical schedules, safety information, training, and owner-facing education that avoids overstating protection. Partnerships with veterinary clinics, laboratories, public-health agencies, animal shelters, breeders, and working-animal organizations can improve surveillance and access. Digital reminders and AI-enabled tools should be introduced with privacy safeguards and clinical validation. Operationally, leaders should strengthen cold-chain reliability, pharmacovigilance, supply continuity, and post-market feedback while adapting communications to local ecology, regulation, and care-seeking behavior.

Research Methodology: Triangulating Epidemiology, Veterinary Practice, and Regulatory Evidence

This executive summary is based on a structured assessment of the veterinary Lyme disease vaccine landscape using the supplied market scope and required geographic groupings. The analytical framework considers peer-reviewed veterinary and medical literature, public surveillance information, regulatory materials, clinical guidance, diagnostic practices, tick ecology, vaccination protocols, and documented changes in companion-animal care. Findings are synthesized qualitatively to identify drivers, barriers, regional differences, institutional-group patterns, country-level considerations, and responsible applications of artificial intelligence. No market estimates, market sizing, market shares, forecasts, or company-specific claims are included.

Conclusion: Risk-Based Vaccination Must Be Paired With Comprehensive Tick Prevention

Veterinary Lyme disease vaccine adoption is best understood within a broader, risk-based prevention system. Differences in tick distribution, animal activity, veterinary access, regulation, and owner awareness make local evidence and professional guidance essential. The strongest long-term approach combines appropriate vaccination with tick control, surveillance, diagnostics, education, and reliable veterinary workflows. Leaders that invest in validated evidence, transparent communication, responsible digital tools, and resilient delivery systems will be better positioned to support safer and more consistent prevention across diverse animal and geographic settings.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Veterinary Lyme Disease Vaccine Market, by Animal Type
7.1. Introduction
7.2. Dog
7.3. Horse
8. Veterinary Lyme Disease Vaccine Market, by Vaccine Type
8.1. Introduction
8.2. Bacterin Inactivated
8.3. Recombinant
8.4. Subunit
9. Veterinary Lyme Disease Vaccine Market, by End User
9.1. Introduction
9.2. Animal Hospitals
9.3. Research Institutes
9.4. Veterinary Clinics
10. Veterinary Lyme Disease Vaccine Market, by Distribution Channel
10.1. Introduction
10.2. Distributors
10.2.1. National Distributor
10.2.2. Regional Distributor
10.3. E-Commerce
10.3.1. Manufacturer Website
10.3.2. Third-Party Marketplace
10.4. Vet Pharmacies
10.4.1. Chain Pharmacy
10.4.2. Independent Pharmacy
11. Veterinary Lyme Disease Vaccine Market, by Administration Route
11.1. Introduction
11.2. Intradermal Injection
11.3. Intramuscular Injection
11.4. Subcutaneous Injection
12. Veterinary Lyme Disease Vaccine Market, by Formulation
12.1. Introduction
12.2. Liquid
12.3. Lyophilized
13. Veterinary Lyme Disease Vaccine Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Veterinary Lyme Disease Vaccine Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Veterinary Lyme Disease Vaccine Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Bimeda Biologicals Inc.
17.2. Bioveta, a.s.
17.3. Boehringer Ingelheim International GmbH
17.4. Dechra Pharmaceuticals PLC
17.5. Elanco Animal Health Incorporated
17.6. Hester Biosciences Limited
17.7. Hipra S.A.
17.8. Merck & Co., Inc.
17.9. Phibro Animal Health Corporation
17.10. US Biologic, Inc.
17.11. Virbac S.A.
17.12. Zoetis Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Veterinary Lyme Disease Vaccine Market, Years Considered for the Study
FIGURE 2. Global Veterinary Lyme Disease Vaccine Market, Research Design
FIGURE 3. Global Veterinary Lyme Disease Vaccine Market, Research Framework
FIGURE 4. Global Veterinary Lyme Disease Vaccine Market, Data Triangulation
FIGURE 5. Global Veterinary Lyme Disease Vaccine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2025 vs 2032 (%)
FIGURE 7. Global Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2025 vs 2032 (%)
FIGURE 9. Global Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Veterinary Lyme Disease Vaccine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Veterinary Lyme Disease Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2025 vs 2032 (%)
FIGURE 15. Global Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2025 vs 2032 (%)
FIGURE 17. Global Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Veterinary Lyme Disease Vaccine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Veterinary Lyme Disease Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Veterinary Lyme Disease Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Veterinary Lyme Disease Vaccine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Veterinary Lyme Disease Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Veterinary Lyme Disease Vaccine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Veterinary Lyme Disease Vaccine Market Segmentation & Coverage
TABLE 2. Global Veterinary Lyme Disease Vaccine Market Size, 2017-2032 (USD Million)
TABLE 3. Global Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 4. Global Dog Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Dog Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Dog Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Horse Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Horse Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Horse Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 11. Global Bacterin Inactivated Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Bacterin Inactivated Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Bacterin Inactivated Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Recombinant Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Recombinant Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Recombinant Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Subunit Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Subunit Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Subunit Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 21. Global Animal Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Animal Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Animal Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 31. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global National Distributor Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global National Distributor Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global National Distributor Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Regional Distributor Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Regional Distributor Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Regional Distributor Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global E-Commerce Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global E-Commerce Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global E-Commerce Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Manufacturer Website Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Manufacturer Website Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Manufacturer Website Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Third-Party Marketplace Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Third-Party Marketplace Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Third-Party Marketplace Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Vet Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Vet Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Vet Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Chain Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Chain Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Chain Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Independent Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Independent Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Independent Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 59. Global Intradermal Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Intradermal Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Intradermal Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Intramuscular Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Intramuscular Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Intramuscular Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Subcutaneous Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Subcutaneous Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Subcutaneous Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 69. Global Liquid Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Liquid Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Liquid Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Lyophilized Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Lyophilized Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Lyophilized Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Veterinary Lyme Disease Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Veterinary Lyme Disease Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 86. North America Veterinary Lyme Disease Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. North America Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 88. North America Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 89. North America Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. North America Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 91. North America Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 92. North America Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 93. North America Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 94. North America Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 95. North America Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 96. Latin America Veterinary Lyme Disease Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Latin America Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 98. Latin America Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 99. Latin America Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Latin America Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 101. Latin America Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 102. Latin America Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 103. Latin America Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 104. Latin America Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 105. Latin America Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 106. Europe Veterinary Lyme Disease Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Europe Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 108. Europe Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 109. Europe Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 110. Europe Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 111. Europe Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 112. Europe Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 113. Europe Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 114. Europe Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 115. Europe Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 116. Middle East Veterinary Lyme Disease Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Middle East Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 118. Middle East Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 119. Middle East Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 120. Middle East Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 121. Middle East Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 122. Middle East Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 123. Middle East Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 124. Middle East Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 125. Middle East Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 126. Africa Veterinary Lyme Disease Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Africa Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 128. Africa Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 129. Africa Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. Africa Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 131. Africa Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 132. Africa Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 133. Africa Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 134. Africa Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 135. Africa Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 136. Global Veterinary Lyme Disease Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. ASEAN Veterinary Lyme Disease Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. ASEAN Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 139. ASEAN Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 140. ASEAN Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. ASEAN Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 142. ASEAN Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 143. ASEAN Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 144. ASEAN Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 145. ASEAN Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 146. ASEAN Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 147. GCC Veterinary Lyme Disease Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 148. GCC Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 149. GCC Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 150. GCC Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. GCC Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. GCC Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 153. GCC Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 154. GCC Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 155. GCC Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 156. GCC Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 157. European Union Veterinary Lyme Disease Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. European Union Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 159. European Union Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 160. European Union Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. European Union Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. European Union Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 163. European Union Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 164. European Union Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 165. European Union Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 166. European Union Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 167. BRICS Veterinary Lyme Disease Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. BRICS Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 169. BRICS Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 170. BRICS Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. BRICS Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. BRICS Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 173. BRICS Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 174. BRICS Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 175. BRICS Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 176. BRICS Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 177. G7 Veterinary Lyme Disease Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. G7 Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 179. G7 Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 180. G7 Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. G7 Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 182. G7 Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 183. G7 Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 184. G7 Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 185. G7 Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 186. G7 Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 187. NATO Veterinary Lyme Disease Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 188. NATO Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 189. NATO Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 190. NATO Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. NATO Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 192. NATO Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 193. NATO Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 194. NATO Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 195. NATO Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 196. NATO Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 197. Global Veterinary Lyme Disease Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 198. United States Veterinary Lyme Disease Vaccine Market Size, 2017-2032 (USD Million)
TABLE 199. United States Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 200. United States Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 201. United States Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. United States Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 203. United States Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 204. United States Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 205. United States Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 206. United States Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 207. United States Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 208. Canada Veterinary Lyme Disease Vaccine Market Size, 2017-2032 (USD Million)
TABLE 209. Canada Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 210. Canada Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 211. Canada Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. Canada Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 213. Canada Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 214. Canada Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 215. Canada Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 216. Canada Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 217. Canada Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 218. Mexico Veterinary Lyme Disease Vaccine Market Size, 2017-2032 (USD Million)
TABLE 219. Mexico Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 220. Mexico Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 221. Mexico Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Mexico Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 223. Mexico Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 224. Mexico Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 225. Mexico Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 226. Mexico Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 227. Mexico Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 228. Brazil Veterinary Lyme Disease Vaccine Market Size, 2017-2032 (USD Million)
TABLE 229. Brazil Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 230. Brazil Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 231. Brazil Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. Brazil Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 233. Brazil Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 234. Brazil Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 235. Brazil Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 236. Brazil Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 237. Brazil Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 238. United Kingdom Veterinary Lyme Disease Vaccine Market Size, 2017-2032 (USD Million)
TABLE 239. United Kingdom Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 240. United Kingdom Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 241. United Kingdom Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. United Kingdom Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 243. United Kingdom Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 244. United Kingdom Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 245. United Kingdom Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 246. United Kingdom Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 247. United Kingdom Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 248. Germany Veterinary Lyme Disease Vaccine Market Size, 2017-2032 (USD Million)
TABLE 249. Germany Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 250. Germany Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 251. Germany Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 252. Germany Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 253. Germany Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 254. Germany Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 255. Germany Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 256. Germany Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 257. Germany Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 258. France Veterinary Lyme Disease Vaccine Market Size, 2017-2032 (USD Million)
TABLE 259. France Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 260. France Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 261. France Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. France Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 263. France Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 264. France Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 265. France Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 266. France Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 267. France Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 268. Russia Veterinary Lyme Disease Vaccine Market Size, 2017-2032 (USD Million)
TABLE 269. Russia Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 270. Russia Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 271. Russia Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. Russia Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 273. Russia Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 274. Russia Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 275. Russia Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 276. Russia Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 277. Russia Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 278. Italy Veterinary Lyme Disease Vaccine Market Size, 2017-2032 (USD Million)
TABLE 279. Italy Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 280. Italy Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 281. Italy Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 282. Italy Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 283. Italy Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 284. Italy Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 285. Italy Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 286. Italy Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 287. Italy Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 288. Spain Veterinary Lyme Disease Vaccine Market Size, 2017-2032 (USD Million)
TABLE 289. Spain Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 290. Spain Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 291. Spain Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. Spain Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 293. Spain Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 294. Spain Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 295. Spain Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 296. Spain Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 297. Spain Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 298. China Veterinary Lyme Disease Vaccine Market Size, 2017-2032 (USD Million)
TABLE 299. China Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 300. China Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 301. China Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 302. China Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 303. China Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 304. China Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 305. China Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 306. China Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 307. China Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 308. India Veterinary Lyme Disease Vaccine Market Size, 2017-2032 (USD Million)
TABLE 309. India Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 310. India Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 311. India Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 312. India Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 313. India Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 314. India Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 315. India Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 316. India Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 317. India Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 318. Japan Veterinary Lyme Disease Vaccine Market Size, 2017-2032 (USD Million)
TABLE 319. Japan Veterinary Lyme Disease Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 320. Japan Veterinary Lyme Disease Vaccine Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 321. Japan Veterinary Lyme Disease Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. Japan Veterinary Lyme Disease Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 323. Japan Veterinary Lyme Disease Vaccine Market Size, by Distributors, 2017-2032 (USD Million)
TABLE 324. Japan Veterinary Lyme Disease Vaccine Market Size, by E-Commerce, 2017-2032 (USD Million)
TABLE 325. Japan Veterinary Lyme Disease Vaccine Market Size, by Vet Pharmacies, 2017-2032 (USD Million)
TABLE 326. Japan Veterinary Lyme Disease Vaccine Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 327. Japan Veterinary Lyme Disease Vaccine Market Size, by Formulation, 2017-2032 (USD Million)
TABLE 328. Australia Veterinary Lyme Disease Vaccine Market Size, 201

Companies Mentioned

  • Bimeda Biologicals Inc.
  • Bioveta, a.s.
  • Boehringer Ingelheim International GmbH
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • Hipra S.A.
  • Merck & Co., Inc.
  • Phibro Animal Health Corporation
  • US Biologic, Inc.
  • Virbac S.A.
  • Zoetis Inc.